macroH2A2在质母细胞瘤中对抗茎的表观遗传程序
Ana Nikolic1,2,3, Francesca Maule1,2, Anna Bobyn1,2,4
1Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Nature communications
|May 27, 2023
概括
基斯变体 macroH2A2 通过控制染色质可访问性来调节质母细胞细胞自我更新. 高的宏H2A2水平与质瘤患者的更好的预后相关,提供了潜在的治疗点.
科学领域:
- 分子生物学分子生物学
- 癌症表观遗传学 癌症表观遗传学
- 质母细胞瘤研究研究
背景情况:
- 自更新是一种关键的质母细胞瘤 (GBM) 细胞特性,由染色质调节剂和转录因子驱动.
- 针对GBM自我更新的表观遗传机制对于开发这种致命癌症的有效治疗方法至关重要.
研究的目的:
- 确定和描述一种新型表观遗传轴调节GBM自我更新.
- 研究基因组变体宏H2A2在GBM自我更新和治疗敏感性中的作用.
主要方法:
- 使用了omics测试 (基因组学,转录组学) 和功能测试.
- 采用患者衍生的体外和体外质母细胞瘤模型.
- 分析了临床队列,以将宏H2A2水平与患者预后相关联.
主要成果:
- macroH2A2 塑造了增强剂元素的染色质可访问性,对抗了GBM自我更新的转录程序.
- macroH2A2通过病毒模仿反应使质母细胞细胞对细胞死亡敏感.
- 临床队列中高宏H2A2表达与改善高度质瘤患者预后有关.
结论:
- macroH2A2代表了质母细胞瘤自我更新的可向的表观遗传调节器.
- macroH2A2可以作为高度质瘤的预后生物标志物.
- 针对宏H2A2介导的表观遗传轴为质母细胞瘤提供了潜在的新疗法策略.
更多相关视频
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
9.7K
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
